Rapid COVID-19 diagnosis and monitoring
Summary
The existing technologies used for diagnosis and monitoring of COVID-19 patients are limited for their usability for home- and remote- settings. In this study, new wearable sensors and point of care devices will be employed to evaluate the feasibiltiy of rapidly detecting of COVID-19 in lab settings and to evaluate the technology performance for monitoring of infected patients at their home. This new diagnostic and monitoring technology will significantly expand the capacity of detecting and monitoring of infected patients and reduce the risk of disease spead.
Eligibility
Eligible gender: Male, Female
Eligible ages: 20 to 80
Accepts healthy participants: Yes
Inclusion criteria:
People who were recently diagnosed with COVID-19 using RT-PCR tests but are categorized as patients with mild or no symptoms are eligible to participate in the immunological study. They will be monitored remotely from their home for a period of one month. Also participants that have been tested for COVID and identified negative to COVID-19 RT-PCR test can participate in this study as control subjects.
Exclusion criteria:
- People who have not been tested for COVID-19
- COVID patients with moderate or severe health conditions
Participate
Additional information
Contact information
Amir Sanati Nezhad, Associate Professor, University of Calgary Email: amir.sanatinezhad@ucalgary.ca
Principal investigator:
Amir Sanati Nezhad
Clinical trial:
No
REB-ID:
REB20-1032